SI-BONE Inc
NASDAQ:SIBN

Watchlist Manager
SI-BONE Inc Logo
SI-BONE Inc
NASDAQ:SIBN
Watchlist
Price: 13.82 USD -1.64% Market Closed
Market Cap: $599.6m

Relative Value

The Relative Value of one SIBN stock under the Base Case scenario is 13 USD. Compared to the current market price of 13.82 USD, SI-BONE Inc is Overvalued by 6%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

SIBN Relative Value
Base Case
13 USD
Overvaluation 6%
Relative Value
Price
Worst Case
Base Case
Best Case

Multiples Across Competitors

SIBN Competitors Multiples
SI-BONE Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
SI-BONE Inc
NASDAQ:SIBN
603.2m USD 3 -31.9 -29.6 -22
US
Abbott Laboratories
NYSE:ABT
187.8B USD 4.2 28.8 16.5 22.7
US
Intuitive Surgical Inc
NASDAQ:ISRG
170.2B USD 16.9 59.6 45.2 55.5
US
Stryker Corp
NYSE:SYK
129B USD 5.1 39.7 20.3 24.5
IE
Medtronic PLC
NYSE:MDT
112.1B USD 3.2 24.3 13.4 19.6
US
Boston Scientific Corp
NYSE:BSX
101.7B USD 5.1 35.1 20.6 27.7
DE
Siemens Healthineers AG
XETRA:SHL
43.5B EUR 1.9 20.6 11.5 16.2
US
Edwards Lifesciences Corp
NYSE:EW
49.1B USD 8.1 45.8 25.2 27.6
US
IDEXX Laboratories Inc
NASDAQ:IDXX
45.5B USD 10.6 43 30.6 33.8
US
Becton Dickinson and Co
NYSE:BDX
45.5B USD 2.1 25.9 10.2 17.2
US
Resmed Inc
NYSE:RMD
33.9B USD 6.3 22.8 16 17.8
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
SI-BONE Inc
NASDAQ:SIBN
Average EV/EBITDA: 21
Negative Multiple: -29.6
N/A N/A
US
Abbott Laboratories
NYSE:ABT
16.5
11%
1.5
US
Intuitive Surgical Inc
NASDAQ:ISRG
45.2
23%
2
US
Stryker Corp
NYSE:SYK
20.3
12%
1.7
IE
Medtronic PLC
NYSE:MDT
13.4
8%
1.7
US
Boston Scientific Corp
NYSE:BSX
20.6
18%
1.1
DE
Siemens Healthineers AG
XETRA:SHL
11.5
10%
1.1
US
Edwards Lifesciences Corp
NYSE:EW
25.2
14%
1.8
US
IDEXX Laboratories Inc
NASDAQ:IDXX
30.6
11%
2.8
US
Becton Dickinson and Co
NYSE:BDX
10.2
1%
10.2
US
Resmed Inc
NYSE:RMD
16
11%
1.5
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
SI-BONE Inc
NASDAQ:SIBN
Average EV/EBIT: 26.3
Negative Multiple: -22
N/A N/A
US
Abbott Laboratories
NYSE:ABT
22.7
18%
1.3
US
Intuitive Surgical Inc
NASDAQ:ISRG
55.5
25%
2.2
US
Stryker Corp
NYSE:SYK
24.5
16%
1.5
IE
Medtronic PLC
NYSE:MDT
19.6
17%
1.2
US
Boston Scientific Corp
NYSE:BSX
27.7
26%
1.1
DE
Siemens Healthineers AG
XETRA:SHL
16.2
15%
1.1
US
Edwards Lifesciences Corp
NYSE:EW
27.6
15%
1.8
US
IDEXX Laboratories Inc
NASDAQ:IDXX
33.8
12%
2.8
US
Becton Dickinson and Co
NYSE:BDX
17.2
15%
1.1
US
Resmed Inc
NYSE:RMD
17.8
12%
1.5
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett